Skip to main content
Fig. 2 | BMC Pulmonary Medicine

Fig. 2

From: Comparison of efficacy and safety of neoadjuvant immunochemotherapy in young and elderly patients with IIA–IIIB non-small-cell lung cancer in real-world practice

Fig. 2

Before matching: The distribution condition of clinical and pathological response: (A) CR/PR/SD, (B) MPR, (C) pCR. After matching: The distribution condition of clinical and pathological response: (D) CR/PR/SD, (E) MPR, (F) pCR. Clinical response included complete response (CR), partial remission (PR), and stable disease (SD). Pathological response included major pathological response (MPR) and pathological complete remission (pCR)

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us